Back to News
investment

Morgan Stanley Maintains Bristol-Myers Squibb Company - Preferred Security (BMYMP) Underweight Recommendation

Nasdaq
Loading...
3 min read
1 views
0 likes
Morgan Stanley Maintains Bristol-Myers Squibb Company - Preferred Security (BMYMP) Underweight Recommendation

Summarize this article with:

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks BMYMP Morgan Stanley Maintains Bristol-Myers Squibb Company - Preferred Security (BMYMP) Underweight Recommendation December 13, 2025 — 04:35 pm EST Written by George Maybach for Fintel-> Fintel reports that on December 12, 2025, Morgan Stanley maintained coverage of Bristol-Myers Squibb Company - Preferred Security (OTCPK:BMYMP) with a Underweight recommendation.

Analyst Price Forecast Suggests 22.58% Upside As of December 6, 2025, the average one-year price target for Bristol-Myers Squibb Company - Preferred Security is $907.12/share. The forecasts range from a low of $565.01 to a high of $1,206.72. The average price target represents an increase of 22.58% from its latest reported closing price of $740.00 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Bristol-Myers Squibb Company - Preferred Security is 49,029MM, an increase of 2.07%. The projected annual non-GAAP EPS is 8.29. What is the Fund Sentiment? There are 14 funds or institutions reporting positions in Bristol-Myers Squibb Company - Preferred Security. This is an increase of 1 owner(s) or 7.69% in the last quarter. Average portfolio weight of all funds dedicated to BMYMP is 0.15%, an increase of 16.99%. Total shares owned by institutions decreased in the last three months by 0.00% to 1,380K shares. What are Other Shareholders Doing? ARBFX - ARBITRAGE FUND Class R holds 858K shares. No change in the last quarter. GAAVX - GMO Alternative Allocation Fund Class VI holds 195K shares. No change in the last quarter. Multi-strategy Growth & Income Fund holds 142K shares. No change in the last quarter. JNL SERIES TRUST - JNL holds 92K shares. No change in the last quarter. AEDFX - WATER ISLAND DIVERSIFIED EVENT-DRIVEN FUND Class R holds 68K shares. No change in the last quarter. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits. Click to Learn MoreThis story originally appeared on Fintel. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags Stocks Fintel Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford. Check out our Unique Analysis of Insider Sentiment for Bristol-Myers Squibb Company - Preferred Security-> Find out what the Options Markets think of Bristol-Myers Squibb Company - Preferred Security-> See our take on Bristol-Myers Squibb Company - Preferred Security Upcoming Earnings-> More articles by this source-> Stocks mentioned BMYMP More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information